X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P8
Near historical low
vs 3Y Ago
-4.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -36.29% |
| Q3 2025 | 21.61% |
| Q2 2025 | -36.58% |
| Q1 2025 | -0.82% |
| Q4 2024 | -3.29% |
| Q3 2024 | 17.94% |
| Q2 2024 | -23.84% |
| Q1 2024 | 75.63% |
| Q4 2023 | 22.06% |
| Q3 2023 | -20.30% |
| Q2 2023 | 40.92% |
| Q1 2023 | 10.33% |
| Q4 2022 | 8.59% |
| Q3 2022 | -10.45% |
| Q2 2022 | -11.94% |
| Q1 2022 | 7.41% |
| Q4 2021 | 20.30% |
| Q3 2021 | 2.19% |
| Q2 2021 | -0.48% |
| Q1 2021 | 8.87% |
| Q4 2020 | -4.32% |
| Q3 2020 | 5.32% |
| Q2 2020 | 18.77% |
| Q1 2020 | 20.03% |
| Q4 2019 | -14.39% |
| Q3 2019 | -3.97% |
| Q2 2019 | -4.77% |
| Q1 2019 | 42.65% |
| Q4 2018 | 41.42% |
| Q3 2018 | 47.93% |
| Q2 2018 | 19.10% |
| Q1 2018 | -42.46% |
| Q4 2017 | -58.24% |
| Q3 2017 | 230.00% |
| Q2 2017 | 21.76% |
| Q1 2017 | 0.00% |
| Q1 2016 | 0.00% |